Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article is for informational purposes only and is not medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before changing your sleep habits, supplement use, or any aspect of your healthcare.

TL;DR

• Japan ranks among the OECD’s shortest-sleeping populations — yet also ranks among the world’s longest-lived.
• A JACC Study Group analysis published in Sleep (Tamakoshi et al., 2004) found a U-shaped relationship between self-reported sleep duration and all-cause mortality in approximately 98,000 Japanese adults. Around 7 hours was associated with the lowest hazard ratio; both shorter and longer sleep were associated with higher mortality.
• The Tsurugaya Project — a community study of elderly residents in Sendai — has examined sleep quality as a component of functional aging, with poor sleep architecture appearing more predictive of functional decline than total duration alone.
• Neither study establishes that sleep duration causes longevity outcomes. Residual confounding from baseline health, depression, and socioeconomic status is present in both.
• Japan’s apparent sleep paradox is most plausibly explained by other factors — diet, walking culture, social structure, preventive medicine access — that are strong enough to offset a modest sleep disadvantage.
• L-theanine (from green tea), magnesium glycinate, and ashwagandha have small-trial evidence associated with improved sleep quality in adults with mild sleep difficulty. None replaces addressing structural sleep barriers.

Japan is among the world’s shortest sleepers — and its longest-lived

Among OECD nations, Japan consistently reports the shortest average sleep time. National survey data from Japan’s NHK Broadcasting Culture Research Institute and the Ministry of Health, Labour and Welfare place average weekday sleep in the 6.5–7.5 hour range, with meaningful proportions of working-age adults sleeping under 6 hours.

This sits in tension with one of the most-cited facts in public health: Japan has the world’s highest life expectancy for women and consistently ranks near the top for men. As of 2022, Japanese women averaged 87.1 years; men, 81.1 years, according to the Ministry of Health, Labour and Welfare 2022 Abridged Life Tables.

The collision of these two facts — shortest sleep, longest life — makes Japan a genuinely interesting setting for examining what sleep duration contributes to longevity outcomes, and what it does not.

What the JACC cohort found

The Japan Collaborative Cohort Study (JACC) enrolled roughly 110,000 Japanese adults from 45 study areas starting in 1988–1990. It was one of the largest prospective cohort studies conducted in Japan at that time.

A sleep-specific analysis by Tamakoshi and colleagues, published in Sleep in 2004, examined the relationship between self-reported sleep duration and all-cause mortality in approximately 98,000 JACC participants followed for about 10 years. The results showed a U-shaped pattern: men and women who reported approximately 7 hours of sleep per night had the lowest hazard ratios for all-cause mortality. Hazard ratios rose on both ends — among those reporting 5 hours or fewer and those reporting 9 hours or more.

Three aspects of this finding are worth examining carefully.

What the U-shape actually means. A U-shaped association does not mean 7 hours is causally optimal. Long sleep duration is heavily confounded by baseline illness: people who are seriously ill often sleep more, and their higher mortality reflects their health status, not the hours spent in bed. Short sleep, by contrast, is more likely to reflect behavioral and socioeconomic factors — night shift work, caregiving obligations, long commutes — all of which carry independent mortality associations. The analysis adjusted for some but not all of these.

The self-report problem. Self-reported sleep duration diverges systematically from actigraphy-measured sleep in almost every population studied. Japanese cultural norms around declaring fatigue — particularly in professional survey contexts — may affect how sleep is reported. People who sleep poorly but work long hours may underreport both.

What the finding does and does not say. The JACC data is consistent with the broader international literature: mortality risk is elevated at the extremes of sleep duration distribution. It does not establish that 7 hours causes better outcomes, and it does not resolve whether Japan’s shorter-than-average sleep is associated with longevity or occurs despite longevity drivers found elsewhere in the Japanese lifestyle profile.

The Tsurugaya Project and elderly sleep patterns

The Tsurugaya Project is a community-based longitudinal study conducted in the Tsurugaya district of Sendai, Miyagi prefecture, examining aging and functional health among Japanese older adults. Unlike the JACC study’s broad working-age enrollment, the Tsurugaya cohort has focused specifically on adults in their 70s and 80s — the population closest to the longevity endpoint.

Research from this cohort has examined sleep quality and duration as components of functional aging. The pattern that appears consistently in this population is that poor subjective sleep quality — specifically fragmented sleep, difficulty maintaining sleep, and early morning awakening — is associated with higher depressive symptom scores and lower functional health measures in older adults.

A separate insight from the Tsurugaya and related Japanese aging cohorts is that the question of whether someone gets 6 or 8 hours appears less predictive of their functional status than the quality of the sleep they do get. This is consistent with polysomnographic research in older adults generally, where sleep architecture — particularly the proportion of slow-wave and REM sleep — declines with age independent of total time. Interventions that target sleep quality (reduced fragmentation, better architecture) may therefore be more actionable for older adults than simply targeting total hours.

The Tsurugaya data does not contradict the JACC U-curve findings; it adds resolution. Duration matters at the extremes; architecture matters throughout.

Why Japan sleeps short — and what this means for the paradox

Japan’s short reported sleep has structural explanations that are relatively well-documented.

Long working hours and commutes. The average one-way commute in greater Tokyo exceeds 40 minutes. Working hours in Japan, while declining under policy pressure since the 2018 Work Style Reform Act, remain elevated relative to most European countries. This leaves less total time for sleep, particularly on weekdays.

Social norms around inemuri. Japan has a well-documented cultural tolerance for inemuri — dozing while appearing to maintain wakefulness, particularly on public transit and in meetings. Researchers have noted this as a partial compensatory mechanism: short nighttime sleep may be partially offset by brief daytime episodes. Whether inemuri provides equivalent physiological rest to consolidated nighttime sleep remains unsettled.

The “sleep debt” national conversation. Around 2017, the concept of suiminsaimu (睡眠負債 — sleep debt) became a prominent public health topic in Japan, driven partly through media coverage and partly through research from the National Center of Neurology and Psychiatry. The discussion acknowledged that Japan’s short sleep was a public health concern, not a longevity advantage — a distinction that wellness content frequently collapses.

The most defensible interpretation of Japan’s longevity-plus-short-sleep pattern is that life expectancy there is driven by diet, social structure, preventive health infrastructure, and declining smoking rates — factors collectively strong enough to compensate for sleep shortfalls that, in populations with weaker lifestyle foundations, might narrow the gap more visibly.

Where sleep support supplements fit — and where they do not

For people whose sleep is genuinely constrained by behavioral or lifestyle factors, the evidence for supplement-based sleep support is modest but real for a small number of compounds.

L-theanine

L-theanine is an amino acid found primarily in green tea leaves (Camellia sinensis). It is the compound most directly linked to green tea’s reputation for promoting a state of calm alertness — associated with alpha-wave EEG patterns in early small-trial human research (Nobre et al., Asia Pacific Journal of Clinical Nutrition, 2008).

Several small trials have found that L-theanine supplementation at 100–200 mg is associated with reduced anxiety and improved sleep quality in adults with stress-related sleep difficulty. A 2019 randomized, double-blind trial in 30 healthy adults (Nutrients, Hidese et al.) found that 200 mg L-theanine daily for four weeks was associated with lower self-reported sleep latency, improved sleep satisfaction, and reduced next-day anxiety and fatigue scores, compared to placebo.

The sample size is small. Effect sizes were moderate. The four-week duration limits conclusions about long-term use. L-theanine’s known safety profile — it is consumed in tens of milligrams per cup of green tea daily by large populations without documented widespread adverse effects — makes it among the lower-risk options for people exploring sleep support.

Available in supplement form at doses typically ranging from 100–400 mg. Search L-theanine supplements on Amazon — look for products that specify Suntheanine (a branded form with documented production standards) or that clearly state the L-theanine content per capsule. For the broader context of L-theanine and cognitive function in Japanese research, see our matcha and L-theanine evidence article.

Magnesium glycinate

Magnesium deficiency is common in Western adult populations — estimates from NHANES data suggest roughly 45–50% of US adults fall below estimated average requirements for magnesium. Low magnesium status is associated with elevated cortisol response and increased sleep fragmentation in some observational analyses.

A 2012 randomized trial in 46 older adults (Journal of Research in Medical Sciences, Abbasi et al.) found that magnesium supplementation at 500 mg daily was associated with significantly improved Insomnia Severity Index scores, sleep efficiency, and sleep onset compared to placebo over 8 weeks. The sample was adults aged 60–75, which limits extrapolation to younger populations with different baseline magnesium status.

Magnesium glycinate is typically better tolerated gastrointestinally than magnesium oxide. Search magnesium glycinate on Amazon. For Japanese dietary sources of magnesium — natto, edamame, hijiki seaweed — see our guide to magnesium-rich Japanese foods.

Ashwagandha (KSM-66)

Ashwagandha (Withania somnifera) is an Indian adaptogenic plant — not Japanese in origin, but it has entered the Japanese supplement market substantially over the past decade and appears frequently alongside Japanese wellness products internationally.

A 2019 randomized, double-blind trial published in Cureus (Langade et al.) enrolled 60 adults and found that KSM-66 standardized extract at 300 mg twice daily was associated with significantly improved self-reported sleep quality, reduced sleep onset latency, and improved morning alertness compared to placebo over 10 weeks. The 600 mg total daily dose is higher than many commercially available doses; check the per-capsule content when comparing products.

Ashwagandha has reported interactions with thyroid medications and sedatives; people on these medications should consult a physician before use. Search ashwagandha KSM-66 supplements on Amazon — look for products that specify the KSM-66 or Sensoril extract, as these have the most documented use in published trials.

The structural question supplements cannot answer

None of the above addresses the behavioral and structural drivers that constrain sleep in modern life: inconsistent sleep timing, late-night screen exposure, alcohol, long work hours, or caregiving obligations. The JACC cohort data suggests that approximately 7 hours is associated with the lowest hazard ratio in a large Japanese population — but no supplement delivers an extra hour of sleep to someone whose schedule does not permit it.

A more realistic target, particularly for adults with genuine schedule constraints, is sleep architecture rather than duration. L-theanine and magnesium have small-trial evidence for improving subjective sleep quality rather than primarily extending total time — this is arguably a more achievable aim than adding a full sleep hour through supplementation alone.

The one thing neither the JACC data nor any supplement research supports: that sleeping fewer than 6 hours carries a longevity advantage. Japan’s life expectancy ranking reflects its dietary pattern, social structures, and health system — not its sleep deficit.

What the evidence actually supports

Several specific positions follow from the available data:

• Approximately 7 hours of self-reported sleep is associated with the lowest all-cause mortality hazard in the JACC cohort. The association is real and directionally consistent with international literature; the causal direction is uncertain.
• Japan’s apparent sleep-longevity paradox is most plausibly explained by confounders — diet, walking culture, social structure, preventive medicine access — rather than by any benefit from short sleep.
• For adults with mild sleep difficulty, L-theanine and magnesium glycinate have the most documented small-trial evidence with the most benign side-effect profiles. Ashwagandha KSM-66 adds evidence on sleep architecture but requires a physician check for people on thyroid or sedative medications.
• Supplements are adjustments to an existing sleep environment, not structural fixes.

For broader context on how Japanese longevity researchers situate sleep alongside diet, exercise, and social connection, see our Blue Zones Japan 2026 research review and the Okinawa centenarian genome research summary. Both provide context for understanding why single-factor explanations — whether short sleep, a specific food, or a longevity gene — tend to underfit what the cohort data shows.

If sleep difficulty is persistent, severe, or accompanied by breathing irregularities, gasping, or witnessed apneas, those are clinical questions for a physician — not supplement questions.

---

Sources: Tamakoshi A, Ohno Y; JACC Study Group. “Self-reported sleep duration as a predictor of all-cause mortality: Results from the JACC study, Japan.” Sleep. 2004;27(1):51–54. Hidese S et al. “Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial.” Nutrients. 2019;11(10):2362. Abbasi B et al. “The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial.” J Res Med Sci. 2012;17(12):1161–9. Langade D et al. “Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study.” Cureus. 2019;11(9):e5797. Ministry of Health, Labour and Welfare Japan, 2022 Abridged Life Tables. Nobre AC, Rao A, Owen GN. “L-theanine, a natural constituent in tea, and its effect on mental state.” Asia Pac J Clin Nutr. 2008;17 Suppl 1:167–8.